BGM Intrinsic Valuation and Fundamental Analysis - BGM Group Ltd

Watchlist Manager

Watchlist

Price: 9.54 USD Market Closed

Market Cap: $127.4m

	BGM Group Ltd NASDAQ:BGM	CN
P	Prada SpA XMUN:PRP	IT
B	Billerud AB (publ) F:BNF	SE
	Bellsystem24 Holdings Inc F:B24	JP
P	Poly Property Group Co Ltd F:CMJ	HK
	SEB SA F:GRB0	FR
	Sunflag Iron and Steel Co Ltd NSE:SUNFLAG	IN
A	Astellas Pharma Inc DUS:YPH	JP

Intrinsic Value

Is BGM undervalued or overvalued?

See the intrinsic value estimate for BGM Group Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BGM Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with BGM’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price $9.54

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What BGM Group Does

Pharmaceuticals Health Care

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Headquarters: China CN
Employees: 323
IPO date: Jan 12, 2021